王蕊, 王宝莲, 李燕. HPLC-MS/MS法研究恒河猴口服新型调血脂化合物IMM-H007后的全血药代动力学特征J. 药学学报, 2018,53(7): 1156-1161. doi: 10.16438/j.0513-4870.2018-0135
引用本文: 王蕊, 王宝莲, 李燕. HPLC-MS/MS法研究恒河猴口服新型调血脂化合物IMM-H007后的全血药代动力学特征J. 药学学报, 2018,53(7): 1156-1161. doi: 10.16438/j.0513-4870.2018-0135
WANG Rui, WANG Bao-lian, LI Yan. Pharmacokinetics of IMM-H007 after oral administration in Rhesus monkey using HPLC-MS/MS analysisJ. Acta Pharmaceutica Sinica, 2018,53(7): 1156-1161. doi: 10.16438/j.0513-4870.2018-0135
Citation: WANG Rui, WANG Bao-lian, LI Yan. Pharmacokinetics of IMM-H007 after oral administration in Rhesus monkey using HPLC-MS/MS analysisJ. Acta Pharmaceutica Sinica, 2018,53(7): 1156-1161. doi: 10.16438/j.0513-4870.2018-0135

HPLC-MS/MS法研究恒河猴口服新型调血脂化合物IMM-H007后的全血药代动力学特征

Pharmacokinetics of IMM-H007 after oral administration in Rhesus monkey using HPLC-MS/MS analysis

  • 摘要: 本研究建立了恒河猴全血中IMM-H007及其主要活性代谢产物M1及MP的HPLC-MS/MS定量测定方法,并成功应用于恒河猴全血药代动力学研究。液相色谱分离采用Capcell PAK ADME柱(2.1 mm×100 mm,3 μm,Shiseido,Japan),流动相为甲醇/水(含0.1%甲酸),梯度洗脱;质谱检测采用电喷雾(ESI)离子源,正离子模式,选择离子检测(SRM)方式测定。经方法学考证,IMM-H007及其代谢产物在恒河猴全血中线性关系良好,批内和批间精密度与准确度偏差均小于15%,回收率高且无基质效应,在样品处理、储存和分析过程中均稳定,说明该测定方法准确、可靠,可满足恒河猴全血动力学研究需要。恒河猴单次口服不同剂量IMM-H007(70、210、630 mg·kg-1)后,原形药IMM-H007在体内血药浓度较低,主要以活性代谢产物M1和MP的形式存在,MP的体内暴露量明显高于M1。MP在恒河猴体内动力学过程符合线性动力学特征。上述研究为新型调血脂药物IMM-H007后续临床前药理毒理和临床研究提供了可靠的参考数据。

     

    Abstract: A simple, sensitive and reliable method was developed for simultaneous quantification of IMM-H007 and its major active metabolites-M1 and MP in the blood of rhesus monkey using HPLC-MS/MS analysis. The analytes and internal standard (IS) WS070119 were separated using a Capcell PAK ADME Column (2.1 mm×100 mm, 3 μm, Shiseido, Japan) with a gradient mobile phase of methanol/water containing 0.1% formic acid. The detection was performed in positive selected reaction monitoring (SRM) mode with electrospray ionization (ESI) source. Satisfactory linearity was obtained while the inter-and intra-assay precision and accuracy differences were no more than 15% with high recovery and good stability for the quantification, indicating the present method was specific, accurate and reliable. The method was successfully applied to the pharmacokinetic study of IMM-H007 in rhesus monkey. After single oral administration of IMM-H007 (70, 210, 630 mg·kg-1), M1 and MP were detected in blood, while the concentration of IMM-H007 was much lower than its metabolites. The active metabolite MP with linear kinetics had a higher exposure than other analytes in vivo. The results provide an useful and reliable model for pharmacological and toxicological studies of IMM-H007 as well as its clinical application.

     

/

返回文章
返回